NetBaseQuid is one of the oldest, most trusted and leading provider of insights in the world. They are able to offer clients a complete end-to-end solution that is tailored to their needs and delivers continuous insights as they grow.

NetBaseQuid knows everything about brands, life events and consumers by utilising a set of automated and machine-learning algorithms that analyse trends on social media channels including Facebook, Twitter, Instagram, Tumblr and Sina Weibo. The company’s team of social data scientists then identify meaningful trends for each client’s business.

NetBaseQuid has been operating for more than 20 years in Europe before expanding into Asia Pacific region in 2014. The company has a global reach with over 200 employees, revenue for the year ending 31 July 2016 was around €14.4 million and an annual growth rate of more than 30%.

NetBaseQuid has been featured in a number of international media outlets including Forbes, The Sunday Times, Bloomberg Businessweek, BBC News and readWrite.

In 2013 NetBaseQuid have won the 2012 Grand Prix du Marketing Social at the Cannes Lions International Festival of Creativity. In 2014 they have won the Best Use of Big Data Award at the UX Asia Awards 2014 and also received a nomination for Best Use of Social Media in Europe at European Marketing Awards 2015 held in Berlin. In drug launch they have been recognized as the Best Use of Data in Pharma at the Digital Pharma Awards.

NetBaseQuid was founded in 1994 by Jos Van Campenhoudt and has grown to more than 200 employees, operating from 4 offices. It has won a number of awards including at Cannes Lions and the European Marketing Awards, and continues to be a leading provider of social intelligence solutions. The company is a proponent of the Open Web Platform and for this reason uses open source technologies such as Hadoop and Elasticsearch in its software stack to give clients access to their insights over standard web services. The company was acquired by Mobiquity International Inc.

With drug launch they have been able to give insight into real-time domestic and international distribution of the medicine, allowing patients to track the status of their medicine online.

NetBaseQuid is a key partner for brands that want to analyze and understand their consumers in a more accurate way. The company has achieved over 10 million customer interactions per month which goes to prove the value of building a relationship with your customers by offering them an open two-way platform. By shouldering this level of engagement NetBaseQuid is able to offer extremely accurate customer insight based on its proprietary algorithms as it crawls each social network for brand mentions, micro-blogging updates and images.

Drug launch therefore remain to be a trend in the digital space and NetBaseQuid have been able to translate these findings into action, enabling companies to monitor their products from launch to commercialization. NetBaseQuid sells a number of products for each vertical it covers and builds these using open-source/open standards technologies such as Hadoop or Elasticsearch. The company’s “unceremonious” acquisition by Mobiquity International Inc., a Hong Kong-based, publicly traded company, won approval from European competition authorities on the condition that NetbaseQuid maintains its autonomy.

With it they monitor the distribution of their products online, allowing patients to track the status of their medicines. This is one of the most popular trends in the on-line space and NetBaseQuid have been able to capitalise on this by developing a set of end-to-end solutions that are tailored to clients needs. As mentioned previously, using open source technologies such as Hadoop enables them to provide these services at a low cost with high availability. The company tracks over 800 million conversations per month and has developed an expertise in social data science and digital analytics that enable it to deliver high quality customised insights for its clients.

You May Also Like

About the Author: John Lucas

Leave a Reply

Your email address will not be published. Required fields are marked *